Edition:
United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

660.00GBp
16 Nov 2018
Change (% chg)

8.10 (+1.24%)
Prev Close
651.90
Open
651.00
Day's High
660.00
Day's Low
641.20
Volume
35,282
Avg. Vol
116,102
52-wk High
1,064.38
52-wk Low
415.05

Chart for

About

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D... (more)

Overall

Beta: -0.38
Market Cap(Mil.): £445.89
Shares Outstanding(Mil.): 66.06
Dividend: --
Yield (%): --

Financials

  OXB.L Industry Sector
P/E (TTM): -- 79.36 29.34
EPS (TTM): -0.02 -- --
ROI: -0.85 -0.30 13.58
ROE: -2.34 -2.98 15.11

Earnings vs. Estimates